Anaheim, Calif. — Max Kley may be the new CEO of Freudenberg Medical, but the goal for the medical device manufacturer remains the same.
Kley took over the top position in August after leading the firm's global Specialty Components division. He's been with Freudenberg since 2000 in increasing areas of responsibility.
"It's great now to have the opportunity to utilize that knowledge and move into a position where you have responsibility for the overall medical world for Freudenberg," Kley said.
His goal is simple: keep Freudenberg Medical on its growth path. Like many suppliers to the medical market, Freudenberg continues to diversify and add capabilities. Most recently, it showcased a number of new technologies at MDM West in Anaheim, targeting the minimally invasive device sector.
It continues to develop its coatings line, something it enhanced by adding a majority stake of Hemoteq AG in 2015.
And regionally, Freudenberg Medical is set to open the second phase of a 13,000-square-foot expansion project in Shenzhen, China. The investment will add an additional 6,000-square-foot clean room that will begin operation this month with four new molding machines and auxiliary equipment to start. The room can accommodate 10 total machines.
"We want to be the leading supplier to the medical device industry within the markets in which we are active," Kley said. "That means leading in technology and offering our customers a full range of services from development to support, advanced supply chain solutions and do it on a global basis. That's why we're investing heavily to build out our network of facilities and development centers all over the world. We see in a market in which consolidation is the name of the game, the players are getting bigger and more global. We have something to offer that really helps our customers."